blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1835939

EP1835939 - MENINGOCOCCAL CONJUGATE VACCINATION [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  20.11.2015
Database last updated on 14.05.2024
Most recent event   Tooltip08.01.2016Lapse of the patent in a contracting state
New state(s): CH, LI		published on 10.02.2016  [2016/06]
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
[2010/21]
Former [2007/39]For all designated states
Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena (SI) / IT
Inventor(s)01 / MARSHALL, Cameron, John
43-45 Bloomsbury Square
London WC1A 2RA / GB
 [2007/39]
Representative(s)Marshall, Cameron John, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2007/39]Marshall, Cameron John, et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date06700004.213.01.2006
[2007/39]
WO2006GB00120
Priority number, dateGB2005000078714.01.2005         Original published format: GB 0500787
[2007/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006075170
Date:20.07.2006
Language:EN
[2006/29]
Type: A1 Application with search report 
No.:EP1835939
Date:26.09.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 20.07.2006 takes the place of the publication of the European patent application.
[2007/39]
Type: B1 Patent specification 
No.:EP1835939
Date:07.04.2010
Language:EN
[2010/14]
Search report(s)International search report - published on:EP20.07.2006
ClassificationIPC:A61K47/48, A61K39/095
[2007/39]
CPC:
A61K39/095 (EP,US); A61P31/04 (EP); A61K2039/545 (EP,US);
A61K2039/6037 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/39]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:MENINGOKOKKEN-KONJUGAT-IMPFUNG[2007/39]
English:MENINGOCOCCAL CONJUGATE VACCINATION[2007/39]
French:VACCINATION À BASE DE CONJUGUÉS ANTIMÉNINGOCCIQUES[2007/39]
Entry into regional phase18.07.2007National basic fee paid 
18.07.2007Designation fee(s) paid 
18.07.2007Examination fee paid 
Examination procedure18.07.2007Examination requested  [2007/39]
26.02.2008Despatch of a communication from the examining division (Time limit: M04)
07.07.2008Reply to a communication from the examining division
08.12.2009Communication of intention to grant the patent
18.02.2010Fee for grant paid
18.02.2010Fee for publishing/printing paid
Divisional application(s)EP10075124.7  / EP2193810
Opposition(s)Opponent(s)01  07.01.2011  07.04.2015  WITHDRAWN
GLAXO SMITHKLINE BIOLOGICALS S.A.
Rue de l'Institut 89
B-1330 Rixensart / BE
Opponent's representative
Johnston, Caroline Louise, et al, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
 02  07.01.2011  23.11.2012  WITHDRAWN
Sanofi Pasteur, Inc.
1 Discovery Drive, Knerr Building 1
Swiftwater, PA 18034 / US
Opponent's representative
Bösl, Raphael Konrad
Patentanwälte Isenbruck Bösl Hörschler PartG mbB
Eastsite One
Seckenheimer Landstraße 4
68163 Mannheim / DE
 [N/P]
Former [2015/20]
Opponent(s)01  07.01.2011  07.04.2015  WITHDRAWN
GLAXO SMITHKLINE BIOLOGICALS S.A.
Rue de l'Institut 89
B-1330 Rixensart / BE
Opponent's representative
Johnston, Caroline Louise, et al, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
 02  07.01.2011  23.11.2012  WITHDRAWN
Sanofi Pasteur, Inc.
1 Discovery Drive, Knerr Building 1
Swiftwater, PA 18034 / US
Opponent's representative
Bösl, Raphael Konrad
Isenbruck Bösl Hörschler LLP
Patentanwälte
Prinzregentenstraße 68
81675 München / DE
Former [2013/02]
Opponent(s)01  07.01.2011  28.01.2011  ADMISSIBLE
GLAXO SMITHKLINE BIOLOGICALS S.A.
Rue de l'Institut 89
B-1330 Rixensart / BE
Opponent's representative
Johnston, Caroline Louise, et al, et al
GlaxoSmithKline 980 Great West Road
GB-Brentford, Middlesex TW8 9GS / GB
 02  07.01.2011  23.11.2012  WITHDRAWN
Sanofi Pasteur, Inc.
1 Discovery Drive, Knerr Building 1
Swiftwater, PA 18034 / US
Opponent's representative
Bösl, Raphael Konrad
Isenbruck Bösl Hörschler LLP Patentanwälte Prinzregentenstraße 68
81675 München / DE
Former [2011/07]
Opponent(s)01  07.01.2011   
GLAXO SMITHKLINE BIOLOGICALS S.A.
Rue de l'Institut 89
B-1330 Rixensart / BE
Opponent's representative
Johnston, Caroline Louise
GlaxoSmithKline 980 Great West Road
GB-Brentford, Middlesex TW8 9GS / GB
 02  07.01.2011   
Sanofi Pasteur, Inc.
1 Discovery Drive, Knerr Building 1
Swiftwater, PA 18034 / US
Opponent's representative
Bösl, Raphael Konrad
Isenbruck Bösl Hörschler LLP Patentanwälte Prinzregentenstraße 68
DE-81675 München / DE
07.02.2011Invitation to proprietor to file observations on the notice of opposition
17.08.2011Reply of patent proprietor to notice(s) of opposition
14.09.2012Date of oral proceedings
05.02.2013Despatch of minutes of oral proceedings
05.02.2013Despatch of communication that the patent will be revoked
21.05.2015Legal effect of revocation of patent [2015/52]
Appeal following opposition12.04.2013Appeal received No.  T0895/13
17.06.2013Statement of grounds filed
21.05.2015Result of appeal procedure: appeal of the proprietor was rejected
21.05.2015Date of oral proceedings
29.05.2015Minutes of the oral proceedings despatched
Fees paidRenewal fee
18.07.2007Renewal fee patent year 03
14.01.2009Renewal fee patent year 04
13.01.2010Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCH07.04.2010
EE07.04.2010
LI07.04.2010
BG07.07.2010
IS07.08.2010
CY13.01.2014
LT13.01.2014
LV13.01.2014
RO13.01.2014
MC31.01.2014
[2016/06]
Former [2014/50]EE07.04.2010
BG07.07.2010
IS07.08.2010
CY13.01.2014
LT13.01.2014
LV13.01.2014
RO13.01.2014
MC31.01.2014
Former [2014/49]EE07.04.2010
BG07.07.2010
IS07.08.2010
CY13.01.2014
LT13.01.2014
RO13.01.2014
MC31.01.2014
Former [2014/48]EE07.04.2010
BG07.07.2010
IS07.08.2010
CY13.01.2014
LT13.01.2014
MC31.01.2014
Former [2014/47]EE07.04.2010
BG07.07.2010
IS07.08.2010
CY13.01.2014
MC31.01.2014
Former [2014/38]EE07.04.2010
BG07.07.2010
IS07.08.2010
MC31.01.2014
Former [2013/42]EE07.04.2010
BG07.07.2010
IS07.08.2010
Former [2011/17]EE07.04.2010
IS07.08.2010
Former [2011/04]IS07.08.2010
Cited inInternational search[XY]WO03094834  (UNIV LEIDEN [NL], et al) [X] 2,4-12,14-18 * page 1, paragraph 8 - page 2, paragraph 9 * * page 3, paragraph L - page 4, paragraph 2 * * page 10, paragraph 8 - page 12, paragraph 3 * * page 12, paragraph 6 - page 14, paragraph 5 * [Y] 1,3,5-18;
 [DY]  - CARLA C.A.M. PEETERS ET AL., "Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines", INFECTION AND IMMUNITY, (1991), vol. 59, no. 10, pages 3504 - 3510, XP000371706 [DY] 1,3,5-18 * abstract * * page 3504, column L, paragraph 1 - page 3505, column L, paragraph 1 * * page 3505, column L, paragraph 4 * * page 3505, column R, paragraph 3 - page 3509, column R, paragraph 1 *
 [DA]  - MOYA BURRAGE ET AL., "Effect of vaccination with carrier protein on response to Meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection", INFECTION AND IMMUNITY, (200209), vol. 70, no. 9, pages 4946 - 4954, XP002352343 [DA] 1-18 * abstract * * page 4947, column L, paragraph 4 * * page 4947, column R, paragraph 2 * * page 4951, column R, paragraph 3 - page 4952, column L, paragraph 1 * * page 4953, column L, paragraph 4 *

DOI:   http://dx.doi.org/10.1128/IAI.70.9.4946-4954.2002
 [A]  - BARRIOS C ET AL, "Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin priming.", EUROPEAN JOURNAL OF IMMUNOLOGY. JUN 1992, (199206), vol. 22, no. 6, ISSN 0014-2980, pages 1365 - 1372, XP002061368 [A] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1002/eji.1830220606
Examination   - UK patent application 0526412.2
by applicantWO03094834
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.